FibroBiologics files patent for engineered cells designed to produce GLP-1 inside body
Bitget2026/10/07 12:31FibroBiologics filed a U.S. patent application for engineered cells designed to continuously produce GLP-1 class peptides inside the body. Approach uses fibroblasts or other cells formed into spheroids or organoids to secrete GLP-1, GIP, or GLP-2 over time. Technology targets a one-time administration to replace repeated injections or pills, aiming for steadier exposure and improved compliance. Patent also covers dual or triple agonist secretion with adjustable hormone ratios, using mixed cell populations or single cells. Application includes control features such as immune-evasion, inducible kill switches, safe-harbor gene insertion, or retrievable encapsulation devices. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DA65633) on October 07, 2026, and is solely responsible for the information contained therein.
- FibroBiologics filed a U.S. patent application for engineered cells designed to continuously produce GLP-1 class peptides inside the body.
- Approach uses fibroblasts or other cells formed into spheroids or organoids to secrete GLP-1, GIP, or GLP-2 over time.
- Technology targets a one-time administration to replace repeated injections or pills, aiming for steadier exposure and improved compliance.
- Patent also covers dual or triple agonist secretion with adjustable hormone ratios, using mixed cell populations or single cells.
- Application includes control features such as immune-evasion, inducible kill switches, safe-harbor gene insertion, or retrievable encapsulation devices.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Canaccord Genuity: Lowers Oklo's target price to $66
Crypto prices
More
